Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11878985 Substituted quinazolines as inhibitors of KRAS G12C

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Tao Wu0

Yuan Liu0

Pingda Ren0

Jun Feng0

Yun Oliver Long0

Yi Liu0

Liansheng Li0

Date of Patent

January 23, 2024

0

Patent Application Number

171259550

Date Filed

December 17, 2020

0

Patent Citations

US Patent 8604017 Azetidinyl diamides as monoacylglycerol lipase inhibitors

0

US Patent 10723738 Inhibitors of KRAS G12C mutant proteins

0

US Patent 10730867 Inhibitors of KRAS G12C mutant proteins

0

US Patent 10736897 Compounds and methods of use thereof for treatment of cancer

0

US Patent 10745385 Covalent inhibitors of KRAS

0

US Patent 10829458 Substituted quinazoline compounds and methods of use thereof

0

US Patent 10858343 Inhibitors of KRAS G12C mutant proteins

0

US Patent 10875842 Inhibitors of KRAS G12C mutant proteins

0

...

Patent Citations Received

US Patent 12134620 Heterocyclic spiro compounds and methods of use thereof for the treatment of cancer

0

Patent Primary Examiner

Douglas M Willis

0

CPC Code

0

0

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11878985 Substituted quinazolines as inhibitors of KRAS G12C

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool